Cerca

FEDERICA MARITATI

Curriculum Vitae

Informazioni personali

Email: federica.maritati@aosp.bo.it

Genere: Female

Esperienza lavorativa

10/2020 - attuale: DIRIGENTE MEDICO NEFROLOGIA @ IRCCS AZIENDA OSPEDALIERO UNIVERSITARIA DI BOLOGNA Policlinico Sant¿Orsola

6/2019 - 9/2020: DIRIGENTE MEDICO NEFROLOGIA @ Ospedali Riuniti di Ancona

5/2017 - 5/2019: Medico specialista in Nefrologia (Libera Professione) @ Azienda Ospedaliero ¿ Universitaria di Parma

10/2016 - 4/2017: Dirigente Medico in Nefrologia @ Ospedale degli Infermi di Biella

6/2015 - 9/2016: Medico specialista in Nefrologia (Libera professione) @ Azienda Ospedaliero ¿ Universitaria di Parma

10/2014 - 3/2015: Trainee doctor @ University College London

Istruzione e Formazione

9/2016 - 12/2019: Dottore di ricerca (PhD) con tesi dal titolo "ENVIRONMENTAL AND OCCUPATIONAL EXPOSURES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS. A CASE-CONTROL STUDY"

5/2010 - 5/2015: Specializzazione in Nefrologia conseguita il 20/05/2015 con votazione di 50/50 con lode. Titolo della tesi di Specializzazione: ¿Rituximab for difficult to treat idiopathic retroperitoneal fibrosis. A case series of 10 patients.¿

9/2003 - 7/2009: Laurea Magistrale in Medicina e Chirurgia conseguita il 16/07/2009 con la votazione di 110/110 con lode. Titolo della tesi di laurea: " Modificazioni immunofenotipiche dei linfociti periferici nella vasculite crioglobulinemica dopo trattamento con un anticorpo monoclonale anti-CD20 (Rituximab)¿

Lingue

  • inglese (B1)

Competenze

Traguardi

  • Busutti M, Maritati F, Borelli G, et al. Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience. J Nephrol. 2024;37(8):2421-2423. doi:10.1007/s40620-024-02005-7Tringali E, Vetrano D, Tondolo F, et al. Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy. Sci Rep. 2024;14(1):16224. Published 2024 Jul 13. doi:10.1038/s41598-024-65857-wPizzuti V, Balducelli E, Nunzio MD, et al. Urine-derived renal epithelial cells isolated after kidney transplant are sensitive to neutrophil gelatinase-associated lipocalin exposure during in vitro culture. Eur J Cell Biol. 2024;103(3):151442. doi:10.1016/j.ejcb.2024.151442Maritati F, Corradetti V, Bini C, et al. "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy. Kidney Int Rep. 2024;9(4):982-993. Published 2024 Jan 10. doi:10.1016/j.ekir.2024.01.013Rubenstein E, Maldini C, Vaglio A, et al. Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis. J Rheumatol. 2023;50(11):1446-1453. doi:10.3899/jrheum.2023-0325Peyronel F, Fenaroli P, Maritati F, Schleinitz N, Vaglio A. IgG4-related disease: advances in pathophysiology and treatment. Expert Rev Clin Immunol. 2023;19(5):537-547. doi:10.1080/1744666X.2023.2195627Maritati F, Provenzano M, Lerario S, et al. Kidney transplantation in systemic sclerosis: Advances in graft, disease, and patient outcome. Front Immunol. 2022;13:878736. Published 2022 Jul 26. doi:10.3389/fimmu.2022.878736Maritati F, Pini R, Comai G, et al. Anastomotic Pseudoaneurysm in Kidney Transplant: A Challenging Management for a Rare Entity. J Endovasc Ther. 2024;31(1):140-145. doi:10.1177/15266028221107882Maritati F, Bini C, Cuna V, et al. Current Perspectives in ABO-Incompatible Kidney Transplant. J Inflamm Res. 2022;15:3095-3103. Published 2022 May 25. doi:10.2147/JIR.S360460Provenzano M, Maritati F, Abenavoli C, et al. Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease. Int J Mol Sci. 2022;23(10):5719. Published 2022 May 20. doi:10.3390/ijms23105719Maritati F, Moretti MI, Nastasi V, et al. ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence?. Case Rep Nephrol Dial. 2021;11(2):214-220. Published 2021 Jul 22. doi:10.1159/000517513 Bello F, Maritati F, Radice A, Sinico RA, Emmi G, Vaglio A. Microarray evaluation of allergen-specific IgE in eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2021;80(9):1247-1248. doi:10.1136/annrheumdis-2021-220111 Bettiol A, Sinico RA, Schiavon F, et al. Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Eur Respir J. 2021;57(5):2004158. Published 2021 May 6. doi:10.1183/13993003.04158-2020 Maritati F, Peyronel F, Fenaroli P, et al. Occupational Exposures and Smoking in Eosinophilic Granulomatosis With Polyangiitis: A Case-Control Study. Arthritis Rheumatol. 2021;73(9):1694-1702. doi:10.1002/art.41722 Fenaroli P, Maritati F, Vaglio A. Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis. Curr Rheumatol Rep. 2021;23(3):18. Published 2021 Feb 10. doi:10.1007/s11926-020-00966-9 Trivioli G, Gopaluni S, Urban ML, et al. Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome. Clin Kidney J. 2020;14(1):332-340. Published 2020 Sep 6. doi:10.1093/ckj/sfaa139
Back to top